- AUD/USD snaps two-day losing streak, while extending bounce off one-week low, despite recently easing from intraday top.
- Vaccine news battles uncertainty over the US stimulus, mixed headlines from China gets less audience.
- US Senate Confirms Jannet Yellen as Treasury Secretary,
- No major data up for publishing amid Australia Day off, updates concerning virus/vaccine and US aid package will be important.
AUD/USD wavers around 0.7715, off intraday high near 0.7720, during the initial Asian trading session on Tuesday. In doing so, the aussie pair struggles to keep 0.7700 while defying the successive declines in the last two days. The reason for the pair’s mixed trading could be traced from the holiday in Australia and a lack of clear risk catalysts elsewhere, not to forget a light calendar.
Risks dwindle despite recent boost…
Latest updates from Moderna and AstraZeneca favored vaccine hopes, even concerning the coronavirus (COVID-19) variants, while news from Israel also suggests a recovery in health following the vaccinations. The news derails the earlier skepticism over the cure to the pandemic.
Read: Covid-19 Vaccine Update: Moderna vaccine effective against UK, SA strains and promising Israeli data
Even so, the risks remain sluggish and the S&P 500 Futures look for a clear direction around 3,850 as doubts over the US fiscal stimulus prevail. US policymakers are jostling over President Joe Biden’s $1.9 trillion relief package amid chatters over a delay in the much-awaited economic aid.
Elsewhere, Australia’s largest customer China surpasses the US when it comes to foreign investments. Though, a Chinese media report marking a proposal to permanently reduce the GDP target dims the earlier optimism.
It’s worth mentioning that Janet Yellen is formally announced as the US Treasury Secretary after the American Senate voted in favor of the decision. The news should ideally help the risks as Yellen recently praised easy money policies.
Given the lack of major data/events on the Asian economic calendar, AUD/USD traders will keep their eyes on the risk catalysts for fresh impulse. In doing so, the latest vaccine hopes and Yellen’s selection can keep the buyers hopeful.
Technical analysis
The symmetrical triangle established since January 04, currently between 0.7665 and 0.7775, restricts short-term AUD/USD moves.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended content
Editors’ Picks
EUR/USD clings to gains near 1.0700, awaits key US data
EUR/USD clings to gains near the 1.0700 level in early Europe on Thursday. Renewed US Dollar weakness offsets the risk-off market environment, supporting the pair ahead of the key US GDP and PCE inflation data.
USD/JPY keeps pushing higher, eyes 156.00 ahead of US GDP data
USD/JPY keeps breaking into its highest chart territory since June of 1990 early Thursday, recapturing 155.50 for the first time in 34 years as the Japanese Yen remains vulnerable, despite looming intervention risks. The focus shifts to Thursday's US GDP report and the BoJ decision on Friday.
Gold price lacks firm intraday direction, holds steady above $2,300 ahead of US data
Gold price remains confined in a narrow band for the second straight day on Thursday. Reduced Fed rate cut bets and a positive risk tone cap the upside for the commodity. Traders now await key US macro data before positioning for the near-term trajectory.
Injective price weakness persists despite over 5.9 million INJ tokens burned
Injective price is trading with a bearish bias, stuck in the lower section of the market range. The bearish outlook abounds despite the network's deflationary efforts to pump the price. Coupled with broader market gloom, INJ token’s doomed days may not be over yet.
Meta takes a guidance slide amidst the battle between yields and earnings
Meta's disappointing outlook cast doubt on whether the market's enthusiasm for artificial intelligence. Investors now brace for significant macroeconomic challenges ahead, particularly with the release of first-quarter gross domestic product (GDP) data on Thursday.